Fluticasone with salmeterol (Seretide) Aerosol inhaler: Supply issue resolved

New stock of Seretide aerosol inhaler 50 mcg with salmeterol 25 mcg (pharmacode 2120194) has arrived in New Zealand.

Reason for the issue

There had been increased demand as people ensured they had adequate supply of Seretide in the face of community spread of COVID-19.

We note there has been increased demand for a range of inhalers.

GSK, the supplier of Seretide inhalers, notified pharmacies about this issue. 

Resupplied 6 April 2022

The supplier advises that stock is now available.

We note that there are delays affecting the supply chain throughout New Zealand.   

Who to contact

If you have questions about the supply of Seretide, email GSK on mel.customersupport@gsk.com 

If you have questions about funding, email enquiry@pharmac.govt.nz